• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Pediatric Healthcare Market

    ID: MRFR/Pharma/17468-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Pediatric Healthcare Market Research Report By Type of Diseases (Short Term Diseases, Chronic Diseases, Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease, Others) and By Treatment (Medication, Surgery, Others) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Pediatric Healthcare Market Infographic
    Purchase Options

    US Pediatric Healthcare Market Summary

    As per MRFR analysis, the US pediatric healthcare market Size was estimated at 13.5 USD Billion in 2024. The US pediatric healthcare market is projected to grow from 14.08 USD Billion in 2025 to 21.5 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.32% during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The US pediatric healthcare market is experiencing transformative growth driven by technological advancements and a heightened focus on mental health.

    • Telemedicine adoption is rapidly increasing, enhancing access to healthcare services for children.
    • There is a growing emphasis on mental health, reflecting a societal shift towards recognizing its importance in pediatric care.
    • Personalized medicine is emerging as a key trend, tailoring treatments to individual patient needs and genetic profiles.
    • The rising pediatric population and increased focus on preventive care are major drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 13.5 (USD Billion)
    2035 Market Size 21.5 (USD Billion)

    Major Players

    Pfizer (US), Johnson & Johnson (US), Merck & Co (US), AbbVie (US), GlaxoSmithKline (GB), Sanofi (FR), Bristol-Myers Squibb (US), AstraZeneca (GB), Novartis (CH)

    US Pediatric Healthcare Market Trends

    Currently experiencing a transformative phase in pediatric healthcare., driven by advancements in technology and a growing emphasis on preventive care. Innovations in telemedicine and digital health solutions are reshaping how healthcare services are delivered to children, making them more accessible and efficient. Parents increasingly seek out these modern solutions, which offer convenience and flexibility in managing their children's health. Furthermore, the focus on mental health has gained traction, with more resources being allocated to address the psychological well-being of younger populations. This shift reflects a broader understanding of health that encompasses both physical and mental aspects, indicating a holistic approach to pediatric care. In addition, Witnessing a rise in personalized medicine., where treatments are tailored to the unique genetic profiles of children. This trend suggests a move towards more effective and targeted therapies, potentially improving outcomes for various conditions. As healthcare policies evolve, there is a growing recognition of the importance of early intervention and continuous care, which may lead to better long-term health trajectories for children. Overall, the landscape of pediatric healthcare is becoming increasingly dynamic, with a clear focus on innovation and comprehensive care strategies that prioritize the needs of children and their families.

    Telemedicine Adoption

    The adoption of telemedicine in the pediatric healthcare market is rapidly increasing, providing families with convenient access to healthcare professionals. This trend allows for remote consultations, reducing the need for in-person visits and enhancing the overall patient experience. Parents appreciate the flexibility and efficiency that telehealth services offer, particularly for routine check-ups and minor health concerns.

    Focus on Mental Health

    There is a growing emphasis on mental health within the pediatric healthcare market, reflecting a broader societal recognition of its importance. Increased funding and resources are being directed towards mental health services for children, aiming to address issues such as anxiety and depression. This trend indicates a shift towards a more comprehensive understanding of child health, encompassing both physical and emotional well-being.

    Personalized Medicine

    The trend towards personalized medicine is gaining traction in the pediatric healthcare market, with treatments increasingly tailored to individual genetic profiles. This approach aims to enhance the effectiveness of therapies for various pediatric conditions, potentially leading to improved health outcomes. As research in genetics advances, the integration of personalized strategies into pediatric care is likely to expand.

    US Pediatric Healthcare Market Drivers

    Rising Pediatric Population

    Experiencing growth due to the increasing number of children in the United States.. According to the U.S. Census Bureau, the population of children under 18 years is projected to reach approximately 73 million by 2025. This demographic shift necessitates enhanced healthcare services tailored to the unique needs of children. As the pediatric population expands, healthcare providers are likely to invest more in specialized pediatric services, thereby driving the market forward. The demand for pediatric healthcare services is expected to rise, leading to increased funding and resources allocated to this sector. Consequently, the pediatric healthcare market is poised for significant growth as stakeholders respond to the evolving needs of a larger pediatric population.

    Increased Focus on Preventive Care

    There is a growing emphasis on preventive care within the pediatric healthcare market, driven by the recognition of its long-term benefits. Healthcare providers are increasingly advocating for regular check-ups, vaccinations, and early screenings to identify potential health issues before they escalate. The Centers for Disease Control and Prevention (CDC) recommends that children receive a series of vaccinations by age two, which has contributed to a rise in preventive healthcare services. This shift towards preventive care is likely to enhance the overall health of the pediatric population, reduce healthcare costs in the long run, and foster a more proactive approach to child health. As a result, Expected to expand as more resources are allocated to preventive services..

    Policy Changes and Healthcare Reforms

    Recent policy changes and healthcare reforms are significantly impacting the pediatric healthcare market. Legislative efforts aimed at improving access to healthcare for children, such as the Children's Health Insurance Program (CHIP), have expanded coverage for millions of children in the United States. These reforms are likely to increase the demand for pediatric healthcare services as more families gain access to necessary care. Additionally, initiatives promoting value-based care are encouraging healthcare providers to focus on quality outcomes rather than volume, which may lead to improved care coordination and patient satisfaction. As these policies continue to evolve, they are expected to shape the landscape of the pediatric healthcare market, fostering an environment conducive to growth and innovation.

    Technological Advancements in Healthcare

    Technological innovations are transforming the pediatric healthcare market, enhancing the quality and accessibility of care. The integration of advanced medical devices, telehealth solutions, and electronic health records (EHR) systems is becoming increasingly prevalent. For instance, the American Academy of Pediatrics has noted that telemedicine usage among pediatricians has surged, with over 60% of pediatricians reporting its implementation in their practices. These advancements not only improve patient outcomes but also streamline operations within healthcare facilities. As technology continues to evolve, it is likely to play a pivotal role in shaping the pediatric healthcare market, facilitating better communication between healthcare providers and families, and ultimately leading to improved healthcare delivery for children.

    Growing Awareness of Pediatric Mental Health

    Witnessing a heightened awareness of mental health issues. affecting children and adolescents. Recent studies indicate that approximately 1 in 6 children aged 2-8 years has a diagnosed mental, behavioral, or developmental disorder. This growing recognition has prompted healthcare providers to prioritize mental health services within pediatric care. Schools and community organizations are increasingly collaborating with healthcare professionals to address mental health needs, leading to a more integrated approach to child health. As mental health becomes a focal point in pediatric care, the market is likely to see an increase in funding and resources dedicated to mental health services, thereby enhancing the overall quality of care for children.

    Market Segment Insights

    By Type of Diseases: Chronic Diseases (Largest) vs. Short Term Diseases (Fastest-Growing)

    In the US pediatric healthcare market, the distribution of disease types reveals that chronic diseases hold the largest market share, reflecting their ongoing impact on long-term patient care. These diseases, which include conditions such as asthma and diabetes, require consistent management and have established a robust healthcare infrastructure around them. In contrast, short term diseases, such as seasonal illnesses, are seeing a rapid increase in market share as awareness and preventive measures grow, particularly among parents seeking immediate care for their children. The growth trends in this segment are fueled by a combination of factors including the rising prevalence of chronic conditions among children and advancements in healthcare technology that facilitate early diagnosis. Additionally, the increasing focus on preventive healthcare and efficiency in treatment options for short term diseases is driving their rapid emergence. Parents are more engaged in their children’s health, contributing to a shift towards managing diseases promptly, thereby expanding both segments' relevance in pediatric healthcare.

    Chronic Diseases: Dominant vs. Short Term Diseases: Emerging

    Chronic diseases are characterized by their long-lasting nature and the need for ongoing medical attention, making them a dominant presence in the US pediatric healthcare market. These diseases often require a comprehensive management approach, including medication, regular check-ups, and lifestyle adjustments, which solidifies their market position. In contrast, short term diseases are emerging rapidly due to contemporary health trends, including a heightened emphasis on vaccinations and immediate care. While they may not have the sustained demand that chronic diseases generate, their quick onset calls for rapid response and treatment solutions, making them increasingly relevant and prioritized in pediatric healthcare services.

    By Therapeutics: Cardiology (Largest) vs. Allergy and Immunology (Fastest-Growing)

    In the US pediatric healthcare market, the distribution of market share among different therapeutic segment values shows that cardiology is the largest, appealing to a significant portion of pediatric patients with congenital and acquired heart diseases. Allergy and immunology, while smaller in share, is rapidly gaining traction due to the increasing prevalence of allergic conditions among children, thus making it a vital area of focus for healthcare providers. The growth trends in these segments are influenced by several factors. Cardiology benefits from advancements in minimally invasive procedures and technologies that enhance diagnostic and treatment options. Meanwhile, the rising incidence of allergies driven by environmental factors and food sensitivities catalyzes growth in the allergy and immunology segment, as both healthcare providers and parents seek effective management strategies for these conditions.

    Cardiology: Dominant vs. Allergy and Immunology: Emerging

    Cardiology stands out as the dominant segment in the US pediatric healthcare market, marked by robust treatment approaches for various heart conditions in children. Innovations in surgical techniques and early diagnosis have reinforced its position. Conversely, allergy and immunology represents an emerging area, reflecting the growing demand for specialized care due to the escalating rates of asthma, food allergies, and eczema in children. This segment is poised for substantial growth, driven by increased awareness, improved screening methods, and the development of new therapeutics tailored specifically for pediatric patients.

    By Treatment: Medication (Largest) vs. Surgery (Fastest-Growing)

    In the US pediatric healthcare market, the Treatment segment is primarily composed of Medication, Surgery, and Other treatment modalities. Currently, Medication holds the largest market share, reflecting its prevalent use in managing pediatric conditions. Surgery follows as the fastest-growing segment, driven by advancements in procedural techniques and increased surgical intervention rates for pediatric patients. The Other treatment category, although smaller, contributes to the diversity of available options for healthcare professionals. Growth trends within the Treatment segment are influenced by several key factors. The rising incidence of chronic diseases among children has led to an increased demand for medications tailored to pediatric patients. Furthermore, the expansion of surgical options due to technological advancements contributes significantly to the Surgery segment's rapid growth. Hospitals and healthcare providers are increasingly investing in state-of-the-art surgical facilities, enabling them to offer more complex interventions, catering to a growing patient population that requires surgical care.

    Medication (Dominant) vs. Surgery (Emerging)

    Medication is the dominant treatment modality in the US pediatric healthcare market, reflecting its fundamental role in managing various pediatric health issues, from common diseases to chronic conditions. This segment encompasses a wide array of pharmaceutical therapies that are specifically formulated for children, ensuring safety and efficacy. On the other hand, Surgery is an emerging segment that is gaining momentum, fueled by innovative surgical techniques and improved patient outcomes. The growing prevalence of minimally invasive surgeries has also enhanced its appeal among parents and healthcare providers alike. As healthcare continues to advance, both segments play critical roles, with Medication remaining foundational and Surgery expanding rapidly to meet the evolving needs of pediatric healthcare.

    Get more detailed insights about US Pediatric Healthcare Market

    Key Players and Competitive Insights

    The pediatric healthcare market in the US is characterized by a dynamic competitive landscape, driven by innovation, regulatory changes, and an increasing focus on preventive care. Major players such as Pfizer (US), Johnson & Johnson (US), and Merck & Co (US) are actively shaping the market through strategic initiatives aimed at enhancing their product offerings and expanding their market reach. Pfizer (US) has positioned itself as a leader in vaccine development, particularly for pediatric populations, while Johnson & Johnson (US) emphasizes its commitment to comprehensive healthcare solutions, including mental health and chronic disease management for children. Merck & Co (US) focuses on research and development, particularly in the realm of infectious diseases affecting children, thereby contributing to a competitive environment that prioritizes innovation and patient-centric solutions.

    Key business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The pediatric healthcare market appears moderately fragmented, with a mix of large multinational corporations and smaller specialized firms. This structure allows for a diverse range of products and services, fostering competition that drives advancements in pediatric care.

    In October 2025, Pfizer (US) announced a partnership with a leading telehealth provider to enhance access to pediatric care through digital platforms. This strategic move is likely to improve patient engagement and streamline healthcare delivery, reflecting a broader trend towards digital transformation in the healthcare sector. By integrating telehealth services, Pfizer (US) aims to address barriers to care, particularly in underserved communities, thereby reinforcing its market position.

    In September 2025, Johnson & Johnson (US) launched a new initiative focused on mental health resources for children and adolescents, collaborating with schools and community organizations. This initiative underscores the company's commitment to holistic healthcare solutions and positions it favorably in a market increasingly concerned with mental health issues among youth. By addressing this critical area, Johnson & Johnson (US) not only enhances its product portfolio but also strengthens its brand loyalty among healthcare providers and parents alike.

    In August 2025, Merck & Co (US) expanded its pediatric vaccine portfolio by acquiring a biotech firm specializing in innovative vaccine technologies. This acquisition is indicative of Merck's strategy to bolster its research capabilities and accelerate the development of next-generation vaccines for children. Such strategic actions are essential for maintaining competitive advantage in a market where vaccine efficacy and safety are paramount.

    As of November 2025, current trends in the pediatric healthcare market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in healthcare delivery. Strategic alliances among key players are increasingly shaping the competitive landscape, facilitating knowledge sharing and resource optimization. Looking ahead, it is anticipated that competitive differentiation will evolve, with a greater emphasis on innovation and technology rather than solely on price. Companies that successfully leverage these trends are likely to emerge as leaders in the pediatric healthcare market, ensuring reliable supply chains and advanced healthcare solutions for children.

    Key Companies in the US Pediatric Healthcare Market market include

    Industry Developments

    The US Pediatric Healthcare Market has recently seen several notable developments, particularly with major institutions enhancing their services and expanding capabilities. In October 2023, Cleveland Clinic Children's announced a partnership with local primary care providers to streamline access to specialized pediatric services, aiming to improve patient outcomes through better coordination of care. In August 2023, UCSF Benioff Children's Hospitals launched a new telehealth initiative to increase access to pediatric specialists across California, particularly benefiting underserved regions. St. Jude Children's Research Hospital continues to focus on innovation in treatment for pediatric cancers, recently unveiling a new clinical trial methodology. 

    In September 2023, Cincinnati Children's Hospital Medical Center reported a significant increase in funding for its Research and Development efforts, demonstrating a commitment to advancing pediatric care. Market growth in the last couple of years has reflected the increasing demand for specialized pediatric healthcare, with Texas Children's Hospital expanding its facilities to accommodate rising patient numbers. Recent trends indicate a focus on telehealth, coordinated care, and advancements in treatment methodologies, contributing positively to the overall valuation and competitiveness of companies within the US Pediatric Healthcare Market.

    Future Outlook

    US Pediatric Healthcare Market Future Outlook

    The pediatric healthcare market is projected to grow at a 4.32% CAGR from 2024 to 2035, driven by technological advancements, increasing healthcare access, and rising awareness of pediatric health issues.

    New opportunities lie in:

    • Telehealth platforms for pediatric consultations
    • Mobile health applications for chronic disease management
    • Partnerships with schools for health education programs

    By 2035, the pediatric healthcare market is expected to be robust, reflecting sustained growth and innovation.

    Market Segmentation

    US Pediatric Healthcare Market Treatment Outlook

    • Medication
    • Surgery
    • Others

    US Pediatric Healthcare Market Therapeutics Outlook

    • Cardiology
    • Allergy and Immunology
    • Gastroenterology
    • Infectious Disease
    • Others

    US Pediatric Healthcare Market Type of Diseases Outlook

    • Short Term Diseases
    • Chronic Diseases
    • Others

    Report Scope

    MARKET SIZE 202413.5(USD Billion)
    MARKET SIZE 202514.08(USD Billion)
    MARKET SIZE 203521.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)4.32% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies Profiled["Pfizer (US)", "Johnson & Johnson (US)", "Merck & Co (US)", "AbbVie (US)", "GlaxoSmithKline (GB)", "Sanofi (FR)", "Bristol-Myers Squibb (US)", "AstraZeneca (GB)", "Novartis (CH)"]
    Segments CoveredType of Diseases, Therapeutics, Treatment
    Key Market OpportunitiesIntegration of telehealth services enhances access to pediatric healthcare for underserved populations.
    Key Market DynamicsRising demand for telehealth services in pediatric healthcare enhances access and efficiency in patient care.
    Countries CoveredUS

    Leave a Comment

    FAQs

    What is the expected market size of the US Pediatric Healthcare Market in 2024?

    The US Pediatric Healthcare Market is expected to be valued at 10.5 billion USD in 2024.

    What will be the market size of the US Pediatric Healthcare Market by 2035?

    By 2035, the US Pediatric Healthcare Market is projected to reach a value of 14.42 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Pediatric Healthcare Market from 2025 to 2035?

    The expected CAGR for the US Pediatric Healthcare Market from 2025 to 2035 is 2.925 percent.

    Which segment is expected to have the largest market share in 2024?

    In 2024, the segment for Chronic Diseases is expected to hold the largest market share, valued at 5.0 billion USD.

    How much is the Short Term Diseases segment valued at in 2024?

    The Short Term Diseases segment is valued at 3.5 billion USD in 2024.

    What are the major players in the US Pediatric Healthcare Market?

    Key players in the US Pediatric Healthcare Market include Cleveland Clinic Children's, Johns Hopkins Children's Center, and Boston Children's Hospital among others.

    What is the projected value of the Others segment by 2035?

    The Others segment is projected to be valued at 3.12 billion USD by 2035.

    What factor is driving growth in the US Pediatric Healthcare Market?

    The increasing prevalence of pediatric chronic diseases is driving growth in the US Pediatric Healthcare Market.

    What are some key applications of the US Pediatric Healthcare Market?

    Key applications include the treatment of Short Term and Chronic Diseases in pediatric care settings.

    How might current global scenarios affect the US Pediatric Healthcare Market?

    Current global scenarios could potentially influence the market dynamics, impacting service delivery and healthcare access.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions